Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts

Quick Read Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% toward the deal price. Danaher stock fell 6.09% on integration concerns. Masimo posted Q3 non-GAAP EPS of $1.32, up 38% year-over-year after selling its consumer audio division. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here. Danaher (NYSE: DHR) is acquiring Masimo (N ...